GlaxoSmithKline (GSK) has announced FDA approval of raxibacumab anti-toxin as a combination therapy along with antibacterial drugs for the treatment of inhalational anthrax in both adult and pediatric patients with limited treatment ...
Eisai's Aciphex (rabreprazole sodium) has met the FDA's Written Request requirements for pediatric exclusivity in US. Having met FDA's requirement, the company has now gained an additional 6 months US market exclusivity for Aciphex, which ...
Tags: rabreprazole sodium, FDA, Aciphex, pediatric drug, GERD Drug
Pluristem Therapeutics, a developer of placenta-based cell therapies, is seeking FDA orphan drug status for its PLacental eXpanded (PLX) cells for the treatment of aplastic anemia. Pluristem earlier received an orphan drug status from the ...
US affiliate of Merz Pharma, Merz has acquired Cuvposa (glycopyrrolate) oral solution, the only FDA approved treatment for pediatric chronic severe drooling (sialorrhea) associated with neurologic conditions such as cerebral palsy. ...
Tags: Merz Pharmaceuticals, CP, Cerebral palsy, Cuvposa
Nonin Medical has launched new Equanox Advance Model 8004CB cerebral/somatic sensor in the US. The Equanox 8004CB cerebral/somatic sensor is designed for use with the company's Equanox Advance Model 7600 Oximetry system in cerebral or ...
In medical diagnostics,protective lead aprons,lead gloves and lead thyroid shields contain lead to shield the wearer from radiation.Lead aprons and other lead clothing are placed between the person being protected and the x-ray source(for ...
Tags: Medical Diagnostics Industry, Lead Clothing, Protect, Medical
Eli Lilly and Company has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), which is available in 20-mg, 30-mg, and 60-mg capsules. As part of the approval, ...